Overview
Barrett’s esophagus (BE) increases the risk of esophageal adenocarcinoma (EAC), a cancer with poor survival rates. Identifying patients most likely to progress remains a challenge, making accurate risk assessment essential to guiding care. In this 30-minute, on-demand CME/MOC educational program, explore how advanced molecular prognostic testing can help refine risk assessment and discover practical strategies for incorporating these tools into BE management and supporting more informed clinical decisions.
Designed for clinicians involved in managing patients with Barrett’s esophagus, the activity features interactive, case-based learning, and clinical practice resources.
Access the programProgram features
- Case-based, interactive online learning module
- Downloadable clinical practice resources
- Podcast and video extensions
- Outcomes measurement
- CME/MOC credit: Earn up to 0.5 AMA PRA Category 1 Credit™ and 0.5 ABIM MOC points.
Learning objectives
As a result of this educational program, learners will be better able to:
- Describe the limitations of traditional approaches to predicting risk of progression to EAC for patients with BE
- Review the evolving role of advanced molecular prognostic tests in assessing risk of progression to EAC in patients with BE
- Outline multidisciplinary strategies to integrate advanced molecular prognostic tests into the management of patients with BE
Key dates
- Released date:
- Oct. 28, 2026
- Expiration date:
- Sep. 22, 2027
Supporter acknowledgment
This program was developed by AGA and Answers in CME (AiCME) and supported by an educational grant from Castle Biosciences, Inc.
Agenda
All times are Eastern.
Session Heading 1: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Session Heading 2: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.